Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
Not yet recruitingNCT07254637
Calcium Pyrophosphate Deposition Disease
Phase 218 years - Not specifiedLomme, Lille, France +8 The aim of this clinical trial is to determine the efficacy of tocilizumab (an IL-6 inhibitor) in treatment-refractory chronic inflammatory forms of CPPD. The main questions this trial aims to answer are: * Can tocilizumab improve joint pain in patie…
RecruitingNCT06351631
Thrombocythemia, Essential · Primary Myelofibrosis · Myelofibrosis · Post-polycythemia Vera Myelofibrosis · Post-essential Thrombocythemia Myelofibrosis · Polycythemia Vera
Phase 318 years - Not specifiedAnn Arbor, Michigan, United States +18 The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bomedemstat, receiving clinical benefit from its use i…
Not yet recruitingNCT07927790
Schizophrenia Disorder · Cognitive Impairments
Not applicable18 years - 60 yearsChangsha, Hunan, China Prefrontal cortical dysfunction in patients with schizophrenia (SCZ) may result from impaired thalamic inputs to this region. Meanwhile, patients with SCZ exhibit a reduced GABA/glutamate ratio in the thalamus, indicating thalamic excitation/inhibiti…
Not yet recruitingNCT07928570
Advanced Malignant Solid Tumor
Phase 1 / Phase 218 years - Not specifiedShanghai, Shanghai Municipality, China This study is an open-label, multicenter, first-in-human (FIH) Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic (PK) profile, and preliminary efficacy of MHB034C in participants with advanced solid tumors.
RecruitingNCT07691970
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
Phase 35 years - 80 yearsPhoenix, Arizona, United States +141 The purpose of this study is to provide continued access to anifrolumab to eligible participants who are continuing to derive clinical benefit from treatment at the end of a parent clinical study, as assessed by the Investigator, while monitoring saf…
Active, not recruitingNCT06694805
HIV Infections
Phase 312 years - Not specifiedBirmingham, Alabama, United States +61 This study will assess how effective, safe, and long-lasting a long-acting antiretroviral therapy (ART) using CAB LA + RPV LA is for people with HIV who still have detectable virus levels despite being on oral ART. The study will also consider feedba…
RecruitingNCT07733973
Cancer
Not applicable21 years - Not specifiedSingapore, Singapore The goal of this clinical trial is to evaluate the communication and care coordinator (CCC) model in a national cancer institute and assess the utility of the model in facilitating serious illness communication (SIC) and care for patients with cancer…
By invitationNCT07328516
Prostate Cancer · Leukemia · Breast Cancer · Melanoma · Colorectal Cancer
Observational18 years - 99 yearsBethesda, Maryland, United States Study Description: ELEA is an observational cohort study that will collect exposure information and biospecimens from the adult children of the Agricultural Health Study (AHS) cohort (https://aghealth.nih.gov/about; Protocol OH93NCN013). The primary …
CompletedNCT07930065
Type 2 Diabetes Mellitus
Not applicable35 years - 75 yearsBeijing, Beijing Municipality, China This randomized crossover trial investigated whether brief, one-minute bouts of exercise, known as "exercise snacks," could improve daytime blood glucose levels in adults with type 2 diabetes who were not receiving insulin treatment. The study also e…
Active, not recruitingNCT04484909
Borderline Resectable Pancreatic Adenocarcinoma · Locally Advanced Pancreatic Ductal Adenocarcinoma · Resectable Pancreatic Ductal Adenocarcinoma · Stage III Pancreatic Cancer AJCC v8
Phase 118 years - Not specifiedHouston, Texas, United States To find the recommended dose of NBTXR3 that can be given in combination with radiation therapy to patients with pancreatic cancer. To learn if the dose NBTXR3 found in Part 1 can help to control the disease.
RecruitingNCT07901816
Pediatric
Not applicable2 years - Not specifiedBuffalo, New York, United States This clinical trial tests the feasibility, acceptability and effect of an optimal defaults grocery shopping intervention to promote healthy diets for pediatric cancer survivors and their families. Pediatric cancer survivors are a growing population w…
RecruitingNCT06066138
Locally Advanced Alveolar Soft Part Sarcoma · Metastatic Alveolar Soft Part Sarcoma · Locally Advanced Non Small Cell Lung Cancer · Metastatic Non Small Cell Lung Cancer · Locally Advanced Small Cell Lung Cancer · Metastatic Small Cell Lung Cancer · Locally Advanced Hepatocellular Carcinoma · Metastatic Hepatocellular Carcinoma · Locally Advanced Melanoma · Metastatic Melanoma
Phase 118 years - 120 yearsBethesda, Maryland, United States Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (at…
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
